Research Article
Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism
Table 4
Correlation between sLOX-1, LDL, and clinicopathological characteristics of NSCLC patients.
| Variables | sLOX-1 (pg/mL) | value | LDL (mmol/L) | value | <1733.0 | ≥1733.0 | <2.715 | ≥2.715 |
| Gender | Male | 20 | 23 | >0.38 | 19 | 24 | 0.15 | Female | 31 | 25 | 33 | 23 |
| Age (years) | <63 | 26 | 23 | 0.76 | 26 | 23 | 0.92 | ≥63 | 25 | 25 | 26 | 24 |
| BMI | <23.3 | 31 | 25 | 0.38 | 33 | 23 | 0.15 | ≥23.3 | 20 | 23 | 19 | 24 |
| Smoking history | Yes | 10 | 15 | >0.18 | 9 | 16 | 0.06 | No | 41 | 33 | 43 | 31 |
| Histology | Squamous cell carcinoma | 9 | 10 | 0.69 | 8 | 12 | 0.21 | Adenocarcinoma | 42 | 38 | 44 | 35 |
| Lymph node metastasis | Yes | 12 | 31 | <0.01 | 16 | 27 | <0.01 | No | 39 | 17 | 36 | 20 |
| Distant Metastasis | Yes | 12 | 14 | <0.01 | 9 | 17 | <0.05 | No | 39 | 34 | 43 | 30 |
| TNM stage | I–II | 35 | 14 | <0.01 | 32 | 17 | <0.01 | III–IV | 16 | 34 | 20 | 30 |
|
|